This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (10)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Julie B. Milstien, PhD; Joel N. Kuritsky, MD
Office of Epidemiology and Biostatistics (HFN-730) Center for Drugs and Biologics Food and Drug Administration 5600 Fishers Lane Rockville, MD 20857

Arch Dermatol. 1986;122(5):511-512.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Eight cases of erythema multiforme (EM) have been reported to the US Food and Drug Administration (FDA) in temporal association with inoculation with the hepatitis B vaccine. The small observed risk of EM is outweighed by the benefits of hepatitis B prevention.

Since the licensing of hepatitis B vaccine in 1982, the FDA, in collaboration with the vaccine manufacturer and the Centers for Disease Control, Atlanta, has been monitoring reported adverse events attributed to the vaccine. Between May 1982¹ and May 1985, eight cases of EM have been reported after inoculation with this vaccine.

Data on the eight recent reports are summarized in the Table. The age range of patients was 24 to 61 years, with a mean age of 36.6 years. The mean time to onset was four days (range, one to nine days). The reported cases were not associated with a particular lot or . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?